tiprankstipranks
Trending News
More News >
Concord Biotech Ltd. (IN:CONCORDBIO)
:CONCORDBIO
India Market

Concord Biotech Ltd. (CONCORDBIO) Ratios

Compare
1 Followers

Concord Biotech Ltd. Ratios

IN:CONCORDBIO's free cash flow for Q3 2025 was ₹0.79. For the 2025 fiscal year, IN:CONCORDBIO's free cash flow was decreased by ₹ and operating cash flow was ₹0.41. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
6.30 6.30 3.79 4.08 5.74
Quick Ratio
4.84 4.84 2.69 2.82 4.29
Cash Ratio
0.11 0.11 0.02 <0.01 0.05
Solvency Ratio
2.08 2.08 1.31 1.07 1.43
Operating Cash Flow Ratio
1.87 1.87 1.28 1.34 1.58
Short-Term Operating Cash Flow Coverage
42.61 42.61 9.84 7.07 5.54
Net Current Asset Value
₹ 9.14B₹ 7.22B₹ 5.04B₹ 4.23B₹ 4.24B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.02 0.05 0.08
Debt-to-Equity Ratio
<0.01 <0.01 0.02 0.06 0.09
Debt-to-Capital Ratio
<0.01 <0.01 0.02 0.05 0.08
Long-Term Debt-to-Capital Ratio
0.00 0.00 <0.01 0.03 0.05
Financial Leverage Ratio
1.11 1.11 1.17 1.19 1.18
Debt Service Coverage Ratio
38.63 38.63 10.21 6.74 8.58
Interest Coverage Ratio
200.32 200.32 72.40 44.49 460.79
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
1.23 1.23 3.45 6.50 8.60
Net Debt to EBITDA
<0.01 -0.01 0.07 0.21 0.25
Profitability Margins
Gross Profit Margin
75.47%75.47%78.88%74.89%80.08%
EBIT Margin
41.59%41.59%38.27%34.30%51.88%
EBITDA Margin
46.68%46.68%44.92%41.97%56.57%
Operating Profit Margin
62.74%62.74%38.27%34.44%50.80%
Pretax Profit Margin
41.34%41.34%37.74%33.53%51.77%
Net Profit Margin
30.87%30.87%28.14%24.69%38.89%
Continuous Operations Profit Margin
30.87%30.87%27.91%24.69%38.96%
Net Income Per EBT
74.68%74.68%74.56%73.65%75.11%
EBT Per EBIT
65.89%65.89%98.62%97.36%101.90%
Return on Assets (ROA)
18.27%18.12%15.86%13.32%19.86%
Return on Equity (ROE)
20.50%20.18%18.61%15.86%23.50%
Return on Capital Employed (ROCE)
24.43%40.18%24.70%21.07%28.50%
Return on Invested Capital (ROIC)
18.35%29.85%18.07%15.12%20.80%
Return on Tangible Assets
18.28%18.12%15.86%13.36%19.97%
Earnings Yield
-1.98%2.43%1.77%2.38%
Efficiency Ratios
Receivables Turnover
2.85 2.85 2.73 2.73 2.83
Payables Turnover
2.59 2.59 1.92 2.14 2.59
Inventory Turnover
1.18 1.18 0.85 0.91 0.78
Fixed Asset Turnover
1.27 1.27 1.11 1.10 1.08
Asset Turnover
0.59 0.59 0.56 0.54 0.51
Working Capital Turnover Ratio
1.55 1.55 1.68 1.45 2.80
Cash Conversion Cycle
234.30 297.12 373.92 363.50 454.17
Days of Sales Outstanding
158.66 127.86 133.87 133.71 128.96
Days of Inventory Outstanding
143.16 310.08 430.03 400.27 465.96
Days of Payables Outstanding
67.52 140.81 189.99 170.49 140.74
Operating Cycle
301.82 437.94 563.90 533.98 594.91
Cash Flow Ratios
Operating Cash Flow Per Share
25.38 25.38 23.51 19.83 15.95
Free Cash Flow Per Share
17.18 17.18 9.65 4.97 -3.57
CapEx Per Share
8.19 8.19 13.87 14.86 19.52
Free Cash Flow to Operating Cash Flow
0.68 0.68 0.41 0.25 -0.22
Dividend Paid and CapEx Coverage Ratio
1.69 1.69 1.24 0.92 0.79
Capital Expenditure Coverage Ratio
3.10 3.10 1.70 1.33 0.82
Operating Cash Flow Coverage Ratio
27.26 27.26 7.80 3.32 1.87
Operating Cash Flow to Sales Ratio
0.27 0.27 0.29 0.29 0.28
Free Cash Flow Yield
0.00%1.15%1.02%0.53%-0.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
50.53 50.53 41.08 56.38 41.99
Price-to-Sales (P/S) Ratio
15.60 15.60 11.56 13.92 16.33
Price-to-Book (P/B) Ratio
10.20 10.20 7.65 8.94 9.87
Price-to-Free Cash Flow (P/FCF) Ratio
86.60 86.60 97.74 189.79 -264.01
Price-to-Operating Cash Flow Ratio
58.65 58.65 40.09 47.54 59.13
Price-to-Earnings Growth (PEG) Ratio
1.78 1.78 1.10 -2.21 1.08
Price-to-Fair Value
10.20 10.20 7.65 8.94 9.87
Enterprise Value Multiple
33.40 33.40 25.81 33.38 29.11
Enterprise Value
17.86M 155.63B 98.91B 99.25B 99.47B
EV to EBITDA
<0.01 33.40 25.81 33.38 29.11
EV to Sales
<0.01 15.59 11.59 14.01 16.47
EV to Free Cash Flow
0.01 86.57 98.01 190.98 -266.26
EV to Operating Cash Flow
<0.01 58.63 40.21 47.84 59.63
Tangible Book Value Per Share
145.90 145.90 123.29 105.11 94.91
Shareholders’ Equity Per Share
145.93 145.93 123.31 105.45 95.53
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.25 0.26 0.25
Revenue Per Share
95.40 95.40 81.55 67.72 57.74
Net Income Per Share
29.45 29.45 22.95 16.72 22.45
Tax Burden
0.75 0.75 0.75 0.74 0.75
Interest Burden
1.00 0.99 0.99 0.98 1.00
Research & Development to Revenue
0.00 0.02 0.04 0.04 0.00
SG&A to Revenue
0.00 0.01 0.01 0.01 0.01
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.67 0.86 0.76 0.87 0.53
Currency in INR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis